The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
India’s vaccine endeavour in fighting the novel coronavirus can truly be termed ‘vaccineyaan’ because it is going all over the world, said Department of Biotechnology Secretary Renu Swarup.